Lipoprotein x: Clinical implications

Annals of Clinical Biochemistry

Volumn 50, Issue 2, 2013, Pages 93-94

  Crook, M A ^a  

^a UNIVERSITY HOSPITAL LEWISHAM   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; CHOLESTEROL; HIGH DENSITY LIPOPROTEIN; INTRALIPID; LIPOPROTEIN X; LITHOCHOLIC ACID; LYSOPHOSPHATIDYLCHOLINE; PHOSPHATIDYLCHOLINE; PHOSPHATIDYLCHOLINE STEROL ACYLTRANSFERASE; PHOSPHOLIPASE;

APHERESIS; CHOLESTASIS; CHOLESTEROL BLOOD LEVEL; CHOLESTEROL SYNTHESIS; EDITORIAL; ELECTROPHORESIS; HUMAN; HYPERCHOLESTEROLEMIA; HYPERLIPIDEMIA; LIPOPROTEIN BLOOD LEVEL; OBSTRUCTIVE JAUNDICE; PRIORITY JOURNAL;

EID: 84879492501     PISSN: 00045632     EISSN: 17581001     Source Type: Journal    
DOI: 10.1177/0004563213478804     Document Type: Editorial

References (29)

1. Stepien KM, Divyateja H, Ahmed F, Prinsloo P, Gupta P. Lipoprotein X in a patient with cholestasis and hypertriglyceridaemia. Ann Clin Biochem 2013. In Press
2. Narayanan S. Biochemistry and clinical relevance of lipoprotein X. Ann Clin Lab Sci 1984;14:371-4
3. Seidel D, Alaupovic P, Furman RH. 'A lipoprotein characterizing obstructive jaundice. I. Method for quantitative separation and identification of lipoproteins in jaundiced subjects'. J Clin Invest 1969;48:1211-23
4. Ross A, Murphy GM, Wilkinson PA, Mills GL, Sherlock S. Occurrence of an abnormal lipoprotein in patients with liver disease. Gut 1970;11:1035-7
5. Turchin A, Wiebe DA, Seely EW, Graham T, Longo W, Soiffer R. Severe hypercholesterolemia mediated by lipoprotein X in patients with chronic graft-versus-host disease of the liver. Bone Marrow Transplant 2005;35:85-9
6. Franceschini G, Busnach G, Chiesa G, Sirtori CR. Management of lipoprotein-X accumulation in severe cholestasis by semi-selective LDL-apheresis. Am J Med 1991;90:633-8
7. Johnson P. Studies in cholestasis of pregnancy. IV. Serum lipids and lipoproteins in relation to duration of symptoms and severity of the disease, and fatty acid composition of lecithin in relation to duration of symptoms. Acta Obstet Gynecol Scand 1975;54:307-13
8. Chang PY, Lu SC, Su TC, et al. Lipoprotein-X reduces LDL atherogenicity in primary biliary cirrhosis by preventing LDL oxidation. Am J Pathol 2004;165:1269-78
9. Brocklehurst D, Lathe GH, Aparicio SR. Serum alkaline phosphatase, nucleotide pyrophosphatase, 50-nucleotide and lipoprotein-X in cholestasis. Clin Chim Acta 1976;67:269-79
10. Baggio M, Heuck G, Seidel CC. Effect of lipoprotein-X on hepatic cholesterol synthesis. Atherosclerosis 1977;26:505-14
11. Rubies-Prat J, Ras MR, Frison JC, Masdeu S, Bacardi R. The clearance of lipoprotein X in vitro, and effect of phospholipase A on serum lipoprotein X. Clin Chim Acta 1977;75:117-21
12. Simon JB, Poon RW. Lipoprotein-X levels in extrahepatic versus intrahepatic cholestasis. Gastroenterology 1978;75:177-80
13. Ritland S, Gjone E. Quantitative studies of lipoprotein-X in familial lecithin: cholesterol acyltransferase deficiency and during cholesterol esterification. Clin Chim Acta 1975;59:109-19
14. Nishiwaki M, Ikewaki K, Bader G Jr., et al. Human lecithin:cholesterol acyltransferase deficiency: in vivo kinetics of low-density lipoprotein and lipoprotein-X. Arterioscler Thromb Vasc Biol 2006;26:1370-5
15. Guérin M, Dolphin PJ, Chapman MJ. Familial lecithin:cholesterol acyltransferase deficiency: further resolution of lipoprotein particle heterogeneity in the low density interval. Atherosclerosis 1993;104:195-212
16. Lynn EG, Choy PC, Magil AOK. Uptake and metabolism of lipoprotein-X in mesangial cells. Mol Cell Biochem 1997;175:187-94
17. Tashiro T, Mashima Y, Yamamori H, Sanada M, Nishizawa M, Okui K. Intravenous intralipid 10% vs. 20%, hyperlipidemia and increase in lipoprotein X in humans. Nutrition 1992;8:155-60
18. Tashiro T, Mashima Y, Yamamori H, et al. Increased lipoprotein X causes hyperlipidemia during intravenous administration of 10% fat emulsion in man. JPEN J Parenter Enteral Nutr 1991;15:546-50
19. Abe M, Kawano M, Tashiro T, et al. Catabolism of lipoprotein-X induced by infusion of 10% fat emulsion. Nutrition 1997;13:417-21
20. Griffin E, Breckenridge WC, Kuksis A, Bryan MH, Angel A. Appearance and characterization of lipoprotein X during continuous intralipid infusions in the neonate. J Clin Invest 1979;64:1703-12
21. Vo H, Gosmanov AR, Garcia-Rosell M, Wall BM. Pseudohyponatremia in acute liver disease. Am J Med Sci 2013;345:62-4
22. Sivakumar T, Chaidarun S, Lee H, Cervinski M, Comi R. Multiple lipoprotein and electrolyte laboratory artifacts caused by lipoprotein X in obstructive biliary cholestasis secondary to pancreatic cancer. J Clin Lipidol 2011;5:324-8
23. Herzum I, Giehl C, Soufi M, Junclas H, Wahl HG. Interference in a homogeneous assay for low-density lipoprotein cholesterol by lipoprotein X. Clin Chem Lab Med 2007;45:667-71
24. Fei H, Maeda S, Kirii H, et al. Evaluation of two different homogeneous assays for LDL-cholesterol in lipoprotein-X-positive serum. Clin Chem 2000;46:1351-6
25. Wolf PL. Clinical significance of serum high-molecular-mass alkaline phosphatase, alkaline phosphatase-lipoprotein-X complex, and intestinal variant alkaline phosphatase. J Clin Lab Anal 1994; 8:172-6
26. Crofton PM, Smith AF. High-molecular-mass alkaline phosphatase in serum and bile: nature and relationship with lipoprotein-X. Clin Chem 1981;27:867-74
27. Bos ES, van der Doelen AA, Denissen AE, Goverde BC, Magnani HN, Kostner GM. A novel assay for the quantitative determination of lipoprotein-X (LP-X) in serum. Clin Chim Acta 1983;127:383-90
28. Hashiguchi Y, Kawaguchi M, Nakanishi M, et al. Simple, direct measurement of lipoprotein X in serum. Clin Chem 1982;28:606-8
29. Talafant E, Tovarek J. Enzymatic determination of lipoprotein-X, a specific serum cholestasis marker. J Clin Chem Clin Biochem 1981;19:155-7